115 related articles for article (PubMed ID: 10761600)
1. [Prevention of sickle cell crises with multiple phlebotomies].
Bouchaïr N; Manigne P; Kanfer A; Raphalen P; de Montalembert M; Hagege I; Verschuur A; Maier-Redelsperger M; Girot R
Arch Pediatr; 2000 Mar; 7(3):249-55. PubMed ID: 10761600
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic phlebotomy during major sickle cell disease in Togo.
Padaro E; Kueviakoe IMD; Agbétiafa K; Magnang H; Mawussi K; Layibo Y; Vovor A
Med Sante Trop; 2019 Feb; 29(1):106-107. PubMed ID: 31031233
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of intermittent iron treatment of two- to six-year-old Jordanian children with iron-deficiency anemia.
Faqih AM; Kakish SB; Izzat M
Food Nutr Bull; 2006 Sep; 27(3):220-7. PubMed ID: 17542112
[TBL] [Abstract][Full Text] [Related]
4. Overt iron deficiency in sickle cell disease.
Haddy TB; Castro O
Arch Intern Med; 1982 Sep; 142(9):1621-4. PubMed ID: 7114979
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
Aloni MN; Lê PQ; Heijmans C; Huybrechts S; Devalck C; Azzi N; Ngalula-Mujinga M; Ferster A
Hematology; 2015 Jun; 20(5):284-8. PubMed ID: 25133935
[TBL] [Abstract][Full Text] [Related]
6. Improvement of sickle cell anemia by iron-limited erythropoiesis.
Castro O; Poillon WN; Finke H; Massac E
Am J Hematol; 1994 Oct; 47(2):74-81. PubMed ID: 7522396
[TBL] [Abstract][Full Text] [Related]
7. Serial evaluation of iron stores in pregnant Nigerians with hemoglobin SS or SC.
Abudu OO; Macaulay K; Oluboyede OA
J Natl Med Assoc; 1990 Jan; 82(1):41-8. PubMed ID: 2304096
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.
Hulbert ML; Panepinto JA; Scott JP; Liem RI; Cook LJ; Simmons T; Brousseau DC;
Transfusion; 2017 Aug; 57(8):1891-1897. PubMed ID: 28500682
[TBL] [Abstract][Full Text] [Related]
10. Sickle cell disease as a cause of osteonecrosis of the femoral head.
Milner PF; Kraus AP; Sebes JI; Sleeper LA; Dukes KA; Embury SH; Bellevue R; Koshy M; Moohr JW; Smith J
N Engl J Med; 1991 Nov; 325(21):1476-81. PubMed ID: 1944426
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload.
Aygun B; Mortier NA; Kesler K; Lockhart A; Schultz WH; Cohen AR; Alvarez O; Rogers ZR; Kwiatkowski JL; Miller ST; Sylvestre P; Iyer R; Lane PA; Ware RE;
Br J Haematol; 2015 Apr; 169(2):262-6. PubMed ID: 25612463
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of painful crises in sickle cell disease by venesections.
Rombos Y; Tzanetea R; Kalotychou V; Konstantopoulos K; Simitzis S; Tassiopoulos T; Aessopos A; Fessas P
Blood Cells Mol Dis; 2002; 28(2):283-7. PubMed ID: 12064923
[TBL] [Abstract][Full Text] [Related]
13. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.
Ware RE; Zimmerman SA; Sylvestre PB; Mortier NA; Davis JS; Treem WR; Schultz WH
J Pediatr; 2004 Sep; 145(3):346-52. PubMed ID: 15343189
[TBL] [Abstract][Full Text] [Related]
14. Heme Iron Concentrate and Iron Sulfate Added to Chocolate Biscuits: Effects on Hematological Indices of Mexican Schoolchildren.
Quintero-Gutiérrez AG; González-Rosendo G; Pozo JP; Villanueva-Sánchez J
J Am Coll Nutr; 2016 Aug; 35(6):544-551. PubMed ID: 27314581
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea therapy in children severely affected with sickle cell disease.
Scott JP; Hillery CA; Brown ER; Misiewicz V; Labotka RJ
J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and acceptance of hydroxyurea in the treatment of severe forms of sickle cell disease: a prospective study of 65 cases].
Mellouli F; Chouaibi S; Dhouib N; Ouederni M; Ben Khaled M; Abbes S; Bejaoui M
Tunis Med; 2013; 91(8-9):544-50. PubMed ID: 24227514
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hypoxemia among children with sickle cell anemia during steady state and crises: a cross-sectional study.
Chinawa JM; Ubesie AC; Chukwu BF; Ikefuna AN; Emodi IJ
Niger J Clin Pract; 2013; 16(1):91-5. PubMed ID: 23377479
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin sickle cell disease complications: a clinical study of 179 cases.
Lionnet F; Hammoudi N; Stojanovic KS; Avellino V; Grateau G; Girot R; Haymann JP
Haematologica; 2012 Aug; 97(8):1136-41. PubMed ID: 22315500
[TBL] [Abstract][Full Text] [Related]
19. Iron in sickle cell disease: a review why less is better.
Koduri PR
Am J Hematol; 2003 May; 73(1):59-63. PubMed ID: 12701123
[TBL] [Abstract][Full Text] [Related]
20. Study of gonadal hormones in Egyptian female children with sickle cell anemia in correlation with iron overload: Single center study.
Hagag AA; El-Farargy MS; Elrefaey S; Abo El-enein AM
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):1-7. PubMed ID: 26684919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
